Acid-lowering cycle of using febuxostat/feblix in patients with high uric acid
Febuxostat (Febuxostat) is a xanthine oxidase inhibitor mainly used to treat hyperuricemia, especially in patients with gout. For patients with high uric acid, febuxostat can effectively reduce blood uric acid levels, relieve gout symptoms, and prevent its recurrence. When treating with febuxostat, formulating a reasonable medication cycle and dosage is the key to successful treatment.

The usual starting dose of febuxostat is40 mg once daily. This dose can effectively help reduce blood uric acid levels in most patients. If a patient's blood uric acid level has not reached the target value of less than 6 mg/dL after 2 weeks of using this dose, the doctor may recommend increasing the dose to 80 mg once daily. By adjusting the dosage, patients can gradually achieve ideal blood uric acid control levels, thereby relieving gout symptoms and preventing complications.
When using febuxostat, it is recommended that patients take the drug on an empty stomach, usually after getting up in the morning, and avoid taking it with food to maximize the absorption and efficacy of the drug. Taking medications on an empty stomach can reduce gastrointestinal discomfort and improve the bioavailability of the medication. During treatment, the patient's blood uric acid level should be monitored regularly to evaluate the therapeutic effect. Based on changes in uric acid levels, doctors will adjust the drug dosage according to the patient's actual condition. After reaching the control goal, maintenance treatment is usually maintained at a dose of 80 mg once daily to stabilize blood uric acid levels.
In general, the use of febuxostat in patients with high uric acid is a gradual process, starting with a low dose and gradually adjusting the dose according to the patient's blood uric acid response to ensure optimal efficacy and minimal adverse reactions. Patients should follow their doctor's instructions and regularly review their blood uric acid levels to ensure long-term effective control of uric acid levels.
Keyword tags: febuxostat, fibril, hyperuricemia, gout, serum uric acid, starting dose, acid-lowering cycle, drug dosage, xanthine oxidase inhibitor, taking on an empty stomach
Reference materials:https://www.drugs.com/uloric.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)